Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q1 2022 call → NOThe question asks whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket — with three conditions: (1) paying now for something not yet earning, (2) the wait is the company's main current work, (3) the far side is a specific, near-dated, already-visible event. Let me examine the transcript for evidence. Key statements from Ricardo Ramos: - "We continue to analyze new ideas and study new projects in all our businesses. We will review our investment plan in the coming months, and we should update our projections following that review. It's very likely that we will increase the resources oriented to the development of business in Chile and abroad." - "In iodine market, we remain on target to increase our capacity 1,000 metric tons next year and 2,500 metric tons in 2024." - "we're increasing our nitrate sole production by 320,000 metric tons, which will allow us to meet future demand growth" - "for lithium, we remain on target to reach the 180,000 metric tons in the coming months, our plan to reach the 210,000 metric tons and 40,000 metric tons of capacity of lithium carbonate and lithium hydroxide respectively advancing well." On Mt. Holland: "we are now facing the moment to decide if we are going to move from 50,000 metric tons to 100,000 metric tons total capacity in our Mt. Holland project. I hope that we will have this decision during second half of this year." On LG partnership: "it's an agreement to review alternatives... I expect to receive a report from those teams, I think the next month. And considering the report, they will recommend moving forward in one or two of many alternatives... I do not expect huge investment at the beginning" Now, does management describe a current, real, ongoing cost being borne for something not yet earning? The transcript doesn't mention specific costs being incurred now for future capacity. The capacity expansions (iodine, nitrates, lithium) are described as "on target" and "advancing well" — these are investments in growth, but management doesn't describe them as a "waiting period" with current costs landing in results. There's no mention of people hired and being paid whose work hasn't begun, no facility being carried before it operates, no inventory bought for volume not yet shipping. The Mt.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.